Navigation Links
Arcxis Biotechnologies Announces Release of First Commercial Product for Molecular Analysis

Arcxis Biotechnologies® announces the launch of ArcPure™ viral DNA and viral RNA sample preparation kits for life science and clinical laboratories.

Pleasanton, CA (PRWEB) October 4, 2009 -- Arcxis Biotechnologies is pleased to announce the availability of their first commercial product line: the ArcPure™ line of nucleic acid isolation and purification kits. These sample preparation kits are optimized to extract and purify viral DNA and RNA from plasma and whole blood. The ArcPure kits are designed to increase downstream assay sensitivity, a critical component of the molecular analytical process. In addition, the product line offers an exceptionally cost effective approach to efficient and expeditious extraction, purification and concentration of nucleic acids using standard laboratory equipment.

The ArcPure line leverages components of the company's patented automated molecular system technologies, currently under development. As such, the kits offer technologists and investigators cutting edge performance in a familiar format, at a significantly lower cost than standard commercially available products. "We were inspired to develop the ArcPure spin-column technology based on the superior performance of Xisyl™, our pre-market automated sample preparation system", commented Arcxis Biotechnologies CEO, Chris Meda. "We are proud of the superior quality of the kits and pleased to offer a robust, cost-effective option to researchers and clinical laboratorians alike."

The ArcPure Sample Preparation kits will initially be available for purchase via the Arcxis e-commerce site, beginning October first.

About Arcxis:
Led by a seasoned team with decades of success in research & development, commercialization and market insight, Arcxis Biotechnologies is focused on developing elegant and cost-effective solutions to today's molecular diagnostic challenges. Incorporated in November 2004, the company holds numerous patents and currently supports its advances in molecular sample processing, target detection, microfluidics and workflow automation with both venture funds (Claremont Creek Ventures, Kaiser Permanente Ventures, Alafi Capial, In-Q-Tel) and cohesive collaborations with leading industry and academic organizations.

For more information about Arcxis Biotechnologies or to order ArcPure Sample Preparation kits, visit:


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement
2. Millennium Biotechnologies Inc. Signs Five Year $20,000,000 Purchase Agreement with Provider Services Inc. of Cleveland, Ohio
3. MDS Analytical Technologies Acquires Blueshift Biotechnologies
4. Veteran of the Beverage Industry, Ken Sadowsky, Joins Millennium Biotechnologies Board of Directors
5. Ezra Van Gelder Joins Microchip Biotechnologies as Executive Vice President R&D
6. Millennium Biotechnologies Reports Strong Third Quarter Revenue and Financial Results
7. Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
8. Epeius Biotechnologies Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer
9. TriLink BioTechnologies, Inc. Announces Sales and License Agreement With Glen Research Corporation for CleanAmp(TM) Amidites
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
Post Your Comments:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
Breaking Medicine Technology: